Cite
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer.
MLA
De Donato, Marta, et al. “KLF7: A New Candidate Biomarker and Therapeutic Target for High-Grade Serous Ovarian Cancer.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 39, no. 1, Nov. 2020, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s13046-020-01775-9.
APA
De Donato, M., Babini, G., Mozzetti, S., Buttarelli, M., Ciucci, A., Arduini, G., De Rosa, M. C., Scambia, G., & Gallo, D. (2020). KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer. Journal of Experimental & Clinical Cancer Research (17569966), 39(1), 1–17. https://doi.org/10.1186/s13046-020-01775-9
Chicago
De Donato, Marta, Gabriele Babini, Simona Mozzetti, Marianna Buttarelli, Alessandra Ciucci, Gloria Arduini, Maria Cristina De Rosa, Giovanni Scambia, and Daniela Gallo. 2020. “KLF7: A New Candidate Biomarker and Therapeutic Target for High-Grade Serous Ovarian Cancer.” Journal of Experimental & Clinical Cancer Research (17569966) 39 (1): 1–17. doi:10.1186/s13046-020-01775-9.